Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
cholesterol
Biotech
Novartis’ Lp(a) drug misses key cardiovascular goal
AI/Digital
MyHeartCode looks beyond cholesterol at heart aging
Biotech
Repair Bio advances plaque regression program with FDA nod
Biotech
Scribe clears first human trial for cholesterol CRISPR
Biotech
Scribe advances safer CRISPR therapies for heart health
Biotech
New data suggests plaque damage can be cleared
Biotech
Investment
Investment
Rafael Holdings gains exclusive MIT Alzheimer’s patent
Biotech
Experimental pill cuts ‘bad cholesterol’ by up to 60%
Research
Supplements
Fasting mimetic shows metabolic effects in trial
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report
